miscsubjectsAI governance
Evidence review

PT-141 and Semaglutide: Layered Evidence for CNS Arousal and Metabolic Load

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-semaglutide`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-semaglutide

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-semaglutide/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-semaglutide/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-semaglutide/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-semaglutide/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why PT-141 might help you

  1. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

Why Semaglutide might help you

  1. What keeps failing: Weight-related joint and disc overload; metabolic stress on repair capacity.
  2. What Semaglutide is studied to do: Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.
  3. Therefore for you: If that layer is part of your problem, Semaglutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.

How these fit together

Each compound above targets a different degeneration layer. Together they are a stack — not five copies of the same mechanism.

  • PT-141 → sexual / CNS arousal
  • Semaglutide → metabolic load / body weight

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 2
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 3

Quantified confidence (this ledger): 0.43 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder (source s1)

Phase 3 RECONNECT trial results for bremelanotide in HSDD.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

STEP trial program summary (source s2)

Human weight-loss magnitude for semaglutide.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

PT 141 for libido — Reddit, r/Biohackers (source s3)

Example anecdotal thread separating PT-141 discussion from semaglutide mentions.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

semaglutide · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedPT-141: Brain-Level Arousal · 17 humanPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood… · 8 humanPT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathw… · 3 humanPT-141 for Diabetic Neuropathy: Evidence-Graded Review · 3 human
Evidence · 3 sources · swipe →chain bd153b0d63ac · verify chain · provenance
1 / 3
Evidence ledger 4 · tier-ranked · API
human
Two identical Phase 3 RECONNECT trials in 1,267 premenopausal women showed bremelanotide 1.75 mg improved FSFI desire scores by +0.35 (p<0.001) versus placebo.
sources: s1
human
No published human trials examine concurrent PT-141 and semaglutide administration.
humanlow confidence
Semaglutide produces average 15 % body-weight loss at 68 weeks in STEP trials.
sources: s2
anecdotallow confidence
Reddit threads contain separate anecdotal reports of PT-141 for libido and semaglutide for weight loss, with no verified combination experiences.
sources: s3
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:09
PT-141 and Semaglutide: Layered Evidence for CNS Arousal and Metabolic Load · 4 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Semaglutide
Slug: pt-141-semaglutide
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"dual_compound","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"pt-141","name":"PT-141"},{"id":"semaglutide","name":"Semaglutide"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's break
it output
{
  "slug": "pt-141-semaglutide",
  "title": "PT-141 and Semaglutide: Layered Evidence for CNS Arousal and Metabolic Load",
  "body": "## What's breaking down\n\nNo single clinical condition is named in the query. Degeneration layers are therefore read from the peptide pairing itself: central nervous system arousal pathways and metabolic/body-weight load on tissues. When repair capacity lags behind daily mechanical and signaling stress, these layers can compound each other. PT-141 is discussed for the arousal/CNS layer. Semaglutide is discussed for the metabolic-load layer. Neither is presented as a symptom mask.\n\n## Why PT-141 might help you\n\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 acts as a melanocortin receptor agonist focused on CNS pathways that influence sexual desire and arousal. Human Phase 3 trials measured changes in validated desire scores rather than peripheral blood flow alone.\n\n## Why Semaglutide might help you\n\n1. **What keeps failing:** Weight-related joint and disc overload; metabolic stress on repair capacity.\n2. **What Semaglutide is studied to do:** Studied for GLP-1-driven weight loss — reduces mechanical load on weight-sensitive tissues.\n3. **Therefore for you:** If that layer is part of your problem, Semaglutide is discussed bec
cdd1d0c02a1ddc0d
Machine verification: /api/articles/pt-141-semaglutide/contributions

Related articles

semaglutide · condition map

Open evidence map →
PT-141: Brain-Level Arousalpt-141PT-141 and Benzodiazepine Withdrawal: A Data-First Evidence Reviewpt-141-benzo-withdrawalPT-141 and Benzodiazepines: Evidence Review on CNS Arousal Layerspt-141-benzodiazepinesPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood…pt-141-blood-pressure-medsPT-141 for Statin-Associated Cognitive Effects: Evidence Reviewpt-141-brain-fogPT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Reviewpt-141-carpal-tunnel
Ask this article · 7 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Two identical Phase 3 RECONNECT trials in 1,267 premenopausal women showed bremelanotide 1.75 mg improved FSFI desire scores by +0.35 (p<0.0…"?
ask pt-141-semaglutide claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "No published human trials examine concurrent PT-141 and semaglutide administration."?
ask pt-141-semaglutide claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "Semaglutide produces average 15 % body-weight loss at 68 weeks in STEP trials."?
ask pt-141-semaglutide claim c2 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit threads contain separate anecdotal reports of PT-141 for libido and semaglutide for weight loss, with no verified combination experie…"?
ask pt-141-semaglutide claim c4 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Example anecdotal thread separating PT-141 discussion from semaglutide mentions."
ask pt-141-semaglutide source s3 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 and Semaglutide: Layered Evidence for CNS Arousal and Metabolic Load — and what would you need me to tell you first?
ask pt-141-semaglutide condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 and Semaglutide: Layered Evidence for CNS Arousal and Metabolic Load (studies vs anecdotes)?
ask pt-141-semaglutide good bad experiences · paste includes §SELF
pt-141-semaglutide · posted 2026-06-29 · updated 2026-07-17 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 2 model passes · 15717 tokens · $0 · 2 models
chain head 04306a5a7f78e8d8
write grok/grok-4.3 · 2026-06-30 01:09 · 15717 tok · 9185d20b9372
voxel_divide owner · 2026-07-17 02:41 · 0 tok · 04306a5a7f78
verify chain →
Live ledger · 3 payloads · 1 turn
recent activity · inspect
JCI_TRAFFIC jci · HTTP 200 · 2026-07-19 04:59
PROTOCOL_RUN dispatch · 2026-06-30 01:09 · t_3r3i259i
PROTOCOL_RUN dispatch · 2026-06-30 01:09 · t_3r3i259i
view full ledger & cards →
REST + ledger
read GET /api/articles/pt-141-semaglutide · GET /api/articles/pt-141-semaglutide?format=post (the editable body)
create/replace POST /api/articles/pt-141-semaglutide · PUT /api/articles/pt-141-semaglutide (replace, keeps revision) · PATCH /api/articles/pt-141-semaglutide (merge)
delete DELETE /api/articles/pt-141-semaglutide
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/pt-141-semaglutide/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/pt-141-semaglutide/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim pt-141-semaglutide|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…